Panel 1 - Beat AML: Progress in Treating Acute Myeloid Leukemia
MODERATOR: RON WINSLOW
Former
Deputy Bureau Chief, Health and Science, The Wall Street Journal
ERKUT BAHCECI, MD
Vice
President, Astellas Pharma
JOHN BYRD, MD
D. Warren
Brown Chair, Leukemia Research, The Ohio State University Comprehensive
Cancer Center
BRIAN DRUKER, MD
Director, OHSU
Knight Cancer Institute; Investigator, Howard Hughes Medical
Institute
ANN T. FARRELL, MD
Division
Director, Hematology Products, Office of Hematology and Oncology Products,
Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food
and Drug Administration
MARINA KONOPLEVA, MD, PhD
Chief,
Leukemia Biology Research, Professor, Department of Leukemia, The
University of Texas MD Anderson Cancer Center
KIMBERLY STEGMAIER, MD
Associate
Professor of Pediatrics, Harvard Medical School; Ted Williams
Chair, Dana-Farber Cancer Institute
Panel 2 - Beyond Blood Cancer: Blood Cancer Research
Advances Helping Other Patients
MODERATOR: JOHN TORRES, MD
Medical
Correspondent, NBC News
SELINA
CHEN-KIANG, PhD
Professor
of Pathology and Laboratory Medicine, Immunobiology and Microbial Pathogenesis,
Weill Cornell Medicine
LOUIS
DEGENNARO, PhD
President
and Chief Executive Officer, The Leukemia & Lymphoma Society
BENJAMIN L.
EBERT, MD, PhD
Professor
of Medicine, Harvard Medical School;
Chair of Medical Oncology, Dana-Farber Cancer Institute
RONALD LEVY,
MD
Summer
Professor of Medicine and Program Leader for Lymphoma, Stanford University
School of Medicine
VALERIE
FIORDILINO MASLOW, PA-C
Hematology/Oncology
Physician Assistant, Cancer Center of South Florida
Multiple sclerosis patient benefiting from a leukemia therapy